The Relationship Between Angiotensin-Converting Enzyme Gene I/D Polymorphism and Psoriasis, Including Psoriasis with Comorbid Hypertension and Diabetes
Jiayun Liu,Rui Sun,Guomin Gao,Mogen Zhang,Huiping Fan,Xiaonan Ma,Yanhong Yu,Yanmei Yuan,Lulu Zhang,Changying Niu
DOI: https://doi.org/10.2147/ccid.s482663
2024-11-13
Clinical Cosmetic and Investigational Dermatology
Abstract:Jiayun Liu, Rui Sun, Guomin Gao, Mogen Zhang, Huiping Fan, Xiaonan Ma, Yanhong Yu, Yanmei Yuan, Lulu Zhang, Changying Niu Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, People's Republic of China Correspondence: Changying Niu, Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, People's Republic of China, Tel +86-536-3081272, Email Objective: The relationship between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and psoriasis remains unclear. This study aims to analyze the association between ACE gene I/D polymorphism and the risk of psoriasis vulgaris in the Chinese Han population and to examine the correlation between ACE gene I/D polymorphism and psoriasis with comorbid hypertension and diabetes. Methods: A total of 358 patients with psoriasis vulgaris and 347 age- and sex-matched healthy volunteers from the Chinese Han population were selected. Clinical data, including blood pressure and fasting blood glucose, were collected from the patients. The ACE gene I/D polymorphism was analyzed using polymerase chain reaction (PCR). The association between ACE gene I/D polymorphism and psoriasis vulgaris, as well as comorbid hypertension and diabetes, was analyzed using the Pearson χ2 -test. Results: The frequency of the ACE II genotype (OR = 1.84, 95% CI = 1.30, 2.61; P < 0.01) and the I allele (OR = 1.51, 95% CI = 1.22, 1.86; P < 0.01) was significantly higher in psoriasis patients compared to the control group. Conversely, the frequency of the ACE DD genotype (OR = 0.62, 95% CI = 0.44, 0.87; P < 0.01) and the D allele (OR = 0.66, 95% CI = 0.54, 0.82; P < 0.01) was significantly lower in psoriasis patients compared to the control group. No statistically significant differences were observed when stratified by blood pressure and blood glucose abnormalities ( P > 0.05). Conclusion: The ACE II genotype and I allele are risk factors for psoriasis vulgaris in the Northern Chinese Han population. Keywords: psoriasis vulgaris, angiotensin-converting enzyme, insertion/deletion mutation, gene polymorphism, Chinese Han ethnic group Psoriasis, characterized by hyperproliferative keratinocytes and immune dysregulation with a genetic predisposition, manifests as scaly erythematous plaques often accompanied by wax drops, thin film phenomena, and Auspitz's sign. These lesions predominantly affect areas such as the scalp, trunk, limbs, and genital regions. The prevalence of psoriasis is about 2–4% worldwide. 1 Remarkably, psoriasis incidence displays regional disparities, with lower rates observed in China and Japan compared to Europe, and its absence noted among indigenous populations in the Andes region of South America. 2 Moreover, individuals with psoriasis face heightened risks of comorbidities like hypertension and diabetes, 3,4 profoundly impacting their well-being, recovery, and long-term prognosis. This multifaceted condition is influenced by a confluence of factors, including ethnicity, genetic makeup, environmental triggers, and aberrant immune responses. At the molecular level, angiotensin-converting enzyme (ACE) assumes a pivotal role in the renin-angiotensin-aldosterone system (RAAS), exerting its effects across various tissues, including the skin, vascular endothelium, lungs, kidneys, and heart. 5,6 ACE catalyzes the conversion of biologically inert angiotensin I (Ang I) into the potent vasoconstrictor angiotensin II (Ang II). Genetically, the ACE gene, situated on chromosome 17q23, 7 encompasses 26 exons and 25 introns, harboring a 287 bp insertion (I)/deletion (D) polymorphism within its 16th intron. This ACE I/D polymorphism dictates functional variations in ACE expression levels, with homozygotes for insertion/insertion (I/I) genotype exhibiting the lowest ACE levels, homozygotes for deletion/deletion (D/D) displaying the highest levels, and heterozygotes (I/D) manifesting intermediate levels. 8,9 Prior investigations have uncovered elevated serum ACE activity in nearly half of psoriasis patients, 10 suggesting a potential interplay between ACE I/D polymorphism and psoriasis pathogenesis. Despite these insights, the precise role of ACE I/D polymorphism in psoriasis remains enigmatic, particularly concerning the Chinese Han population, where research is scarce. Hence, exploring the association between ACE gene I/D polymorphism and the risk of psoriasis vulgaris in the Chinese Han population is crucial for several reasons. Firstly, psorias -Abstract Truncated-
dermatology